Sign in
Taking people in South AfricaNo phase

Tests peer mentoring to reduce alcohol use in pregnant women in South Africa

Tests peer mentoring to cut alcohol use in pregnant and breastfeeding women.

Key facts

Who runs it
University of California, Los Angeles
Where
Cape Town and Saldanha Bay, South AfricaSee the 2 sites
Trial code
Registry title
Mentor Moms+ Study
Status
Recruiting
People taking part
100 people, planned
Started
1 Sept 2025
Expected to end
31 Aug 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • MM+
  • Enhanced HIV attention control (eSOC)
Record updated
2 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for pregnant women aged 16 or older who used alcohol during pregnancy. It tests peer mentoring sessions to reduce alcohol use.

Age
16 years or older
Sex
Women only
Disease stage
Confirmed pregnancy. Alcohol use reported in the last 2 months.

Main reasons for not taking part

  • Not living within 20 kilometers (12 mi) of the study facility
  • Not able or not willing to consent to take part

This trial only enrols pregnant participants. The registry sentence this rests on: Pregnancy confirmed;

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • • ≥ 16 years; Pregnancy confirmed; reported alcohol use during pregnancy (in last 2 months); lives within 20 kilometers of the study facility; able and willing to consent to study participation

Who cannot take part

  • Individuals not meeting the above criteria will be excluded

This trial is currently available in South Africa.

  • Saldanha Bay Municipality ClinicCape Town, South AfricaContact: Zaynab Essack, PhDNot yet recruiting
  • Saldanha Bay ClinicsSaldanha Bay, South AfricaContact: Zaynab Essack Principal Investigator, PhDTaking people

About the trial

What the trial wants to find out

The goal of this study is to adapt an existing evidence based intervention for use in pregnant and lactating people (PLP) who use alcohol. Through the pilot RCT, we aim to understand if tailored intervention, Mentor Mothers+, is effective in reducing alcohol use (primary outcome) and improving antiretroviral (PrEP or ART) adherence (secondary outcomes) among pregnant and breastfeeding women living with and without HIV in a community heavily burdened by this syndemic.

Read full original descriptionShow less

The investigators will conduct an pilot randomized control trial in 100 pregnant women, recruited during antenatal care (ANC) visits within the Saldanha Bay Municipality clinic in Cape Town, South Africa. The RCT will involve the delivery of brief, individual motivational interviewing sessions provided by trained mentor mothers from the community who are on either PrEP (living without HIV) or ART (living with HIV) and who stopped or reduced alcohol use during pregnancy. The enrolled participants will be followed for a 6-month period spanning both pregnancy and postpartum stages.

The 2 groups in the trial

  • MM+ InterventionTreatment being tested

    MM+ will involve mentor mother delivery of brief MI sessions individually over a series of clinic- based visits over a 6m period during pregnancy and postpartum. Intervention content, duration, and full menu of HIV prevention services offered will be finalized prior to launch. We anticipate no fewer than five to six 15-20 minute MI sessions focused on the benefits of reducing alcohol use during pregnancy, managing HIV risk among women without HIV and importance of ART use and viral suppression for reducing the risk of vertical transmission. Participants in MM+ arm will receive enhanced HIV prevention counseling integrated into routine antenatal care visits, including PrEP and ART biofeedback adherence counseling, provided by a trained study nurse. Participants in the intervention arm will also receive EtG testing (alcohol use) and corresponding biofeedback counseling.

    Treatment: MM+

  • Enhanced HIV attention control (eSOC)Existing treatment, for comparison

    Similar to placebo pills, attention control is often used in randomized trials for behavioral interventions to control for the nonspecific effects of the intervention. Given that existing MM models focus on prevention of vertical transmission and HIV treatment and our primary interest is understanding how inclusion of alcohol reduces alcohol use improves adoption of ART/PrEP use, we will use an enhanced HIV attention control with the same time frame for the intervention (e.g. 2-3 sessions during antenatal/and 2-3 sessions during postpartum periods). Sessions will consist of educational counseling on HIV risk, partner testing modalities as well as PrEP/ART urine assay testing followed by real-time in-clinic adherence counseling delivered privately by lay counselors (different from MM+ arm to avoid contamination), all coinciding with routine ANC visits when possible.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Community-based Adaptation of a Peer-led Intervention to Address Alcohol Use and HIV Risk in Pregnant Women in South Africa (Mentor Moms+)
Plain-language title
Tests peer mentoring to reduce alcohol use in pregnant women in South AfricaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Publications
Record updated
2 July 2026